Dr. Anjali Kapoor

So circling back to what we talked about earlier regarding the implantable tibial neuromodulators.

Currently, are you doing I know they're being designed to potentially do them in the office one day, but for various reasons, they need to be done in an ambulatory surgery center or hospital.

Can you talk a little bit about that?

So I think that was a very informative talk.

I think we were able to cover a lot of ground between what's changed in the guidelines and especially with all of the new education we received at SUFU this year from abstracts that came out on all of these therapies.

And the long term or, you know, one and two year outcomes of several of these therapies.

So just to summarize, if you had to compare overactive bladder diagnosis and treatment today compared to, say, 10 years ago or when you started practice, what would you say are some of the key changes that there's been?

It feels great for me entering the field at this point because I have kind of everything at my fingertips to be able to offer and to learn these procedures so that I can offer them to my patients as well.

I have a lot of that to contribute to you.

Yeah.

No, it's nice to be passionate about something.

What are some of your ongoing or future research projects, some of your passions within urogynecology, reconstructive pelvic surgery, or overactive bladder particularly?

Yeah, and that will definitely help increase adherence to therapy or reduce discontinuation if we are able to pinpoint which patients might respond better to a certain therapy.

Well, great.

I think that'll about wrap it up unless you have anything else to add.

Thank you.

I appreciate it.

Social media and PR by Chi Dang.

Administrative support provided by Judy De La Cruz.